CME webinar: Fluoride Varnish and the Pediatric Patient – Making It Work for Your Office

Jun. 2023Education/Webinars
Please join us for a live, CME-accredited webinar Wednesday, Aug. 9, from noon to 1 p.m. that will provide an overview of topical fluoride varnish. This webinar is being offered as part of the Pediatric Collaborative Call series.

During this presentation, experts will discuss:
  • How to understand the oral health benefits of fluoride.
  • How applying fluoride varnish can impact the medical office.
  • The future implications of applying fluoride varnish.

Presenters:
  • Richard Celko, DMD, MBA, Chief Dental Officer, UPMC; Adjunct Assistant Professor, University of Pittsburgh School of Dental Medicine
  • Tanya Gayley, BSDH, RDH, PHDHP, EFDA, Dental Care Manager
  • Barbara Hammerschmitt, MPH, RDH, PHDHP, Dental Care Manager
  • Nora Lugaila, BSDH, RDH, PHDHP, Dental Care Manager
  • Rebecca Nagle, MS, BSN, RN CPHQ, Director of Medicaid and CHIP Quality Program
  • Deborah Moss, MD, MPH, FAAP, Professor of Pediatrics, Children’s Hospital of Pittsburgh; Pediatric Medical Director, UPMC Health Plan

Register for the 'Fluoride Varnish and the Pediatric Patient: Making It Work for Your Office' webinar now. This webinar will be recorded.

Provider is responsible for verifying continuing medical education (CME) eligibility.

You may earn continuing medical education (CME) credits for attending this webinar. This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Recent Announcements

Voluntary nationwide recall: Atorvastatin (Alkem – October)

Ascend Laboratories LLC is recalling multiple lots of Atorvastatin Calcium Tablets USP. Atorvastatin is used for the treatment of high cholesterol and to reduce the risk of certain cardiovascular events, such as heart attack and stroke.
Nov. 2025Pharmacy Updates

October 2025 UPMC for You and UPMC Community HealthChoices formulary update

Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.
Oct. 2025Pharmacy Updates

Voluntary nationwide recall: Ocaliva (Intercept – September)

Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).
Oct. 2025Pharmacy Updates